Top Markets
Coin of the day
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Rang in aandelen #40711
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Aandeelprijs
$0.065
Laatst gesynchroniseerd: 2025-01-10
Marktkapitalisatie
$94.10K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel TFF Pharmaceuticals, Inc. (TFFP)

Categorie

Prijs TFFP met de marktkapitalisatie van B
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
TFFP
$0.065
Marktkapitalisatie van TFF Pharmaceuticals, Inc.(TFFP)
Marktkapitalisatie: $94.10K
Vanaf August 2026 heeft TFF Pharmaceuticals, Inc. een marktkapitalisatie van $94.10K. Dit maakt TFF Pharmaceuticals, Inc. volgens onze gegevens het 40711th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van TFF Pharmaceuticals, Inc. van 2019 tot 2026
TFFP vergeleken met de top 5 populairste stocks
Prijs voor TFFP Aandeel B Marktkapitalisatie van B uitslagen
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,774,046 $94.10K
$5.464T +5,806,224,497.04%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,079,112 $94.10K
$4.458T +4,737,094,655.68%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,883,861 $94.10K
$4.175T +4,436,709,234.83%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,534,018 $94.10K
$3.669T +3,898,488,821.25%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$1,970,946 $94.10K
$2.853T +3,032,224,925.51%